| Susan Terrell, ARNP | |
|
116 E 11th St, Suite 101, Spencer, IA 51301-4364 | |
| (712) 264-3500 | |
| (712) 264-3535 |
| Full Name | Susan Terrell |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 116 E 11th St, Spencer, Iowa |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447230081 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | A-057096 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Susan Terrell, ARNP 116 E 11th St, Suite 101, Spencer, IA 51301-4364 Ph: (712) 264-3500 | Susan Terrell, ARNP 116 E 11th St, Suite 101, Spencer, IA 51301-4364 Ph: (712) 264-3500 |
News Archive
Although it reads like European license plate number, a protein known as ZMYND8 has demonstrated its ability to block metastasis-linked genes in prostate cancer, according to a study at The University of Texas MD Anderson Cancer Center.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that new clinical data from a Phase 1b trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with paclitaxel (Taxol), a standard chemotherapy regimen, will be presented during the 33rd Annual San Antonio Breast Cancer Symposium (SABCS) being held December 8-12, 2010 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
With seed money from the National Science Foundation (NSF), bioengineers from the University of California, Berkeley, and Stanford University are ramping up efforts to characterize the thousands of control elements critical to the engineering of microbes so that eventually, researchers can mix and match these "DNA parts" in synthetic organisms to produce new drugs, fuels or chemicals.
A multi-year, ongoing study suggests that a new kind of gene therapy for hemophilia B could be safe and effective for human patients. Published in the journal Science Translational Medicine, the research showed that a reprogrammed retrovirus could successfully transfer new factor IX (clotting) genes into animals with hemophilia B to dramatically decrease spontaneous bleeding.
AVANIR Pharmaceuticals, Inc. today announced that it has received a "Notice of Allowance" from the United States Patent and Trademark Office (USPTO) announcing that it intends to grant the Company a new patent, extending the period of commercial exclusivity for its lead drug candidate Zenvia™ well into 2025.
› Verified 5 days ago
Kathi Kae Heckert, CNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 116 E 11th St, Ste 101, Spencer, IA 51301 Phone: 712-264-3500 Fax: 712-264-3535 | |
Sara Casey, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 116 E 11th St, Spencer, IA 51301 Phone: 712-264-3500 | |
Kimberly Goslinga, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 201 E 11th St, Spencer, IA 51301 Phone: 800-242-5101 | |
Jill A. Hustedt, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 337 11th St Sw, Spencer, IA 51301 Phone: 712-792-7500 Fax: 712-792-7510 | |
Leisha Fischer, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 116 East 7th Street, Suite 2, Spencer, IA 51301 Phone: 712-580-6592 Fax: 712-580-6593 | |
Kathryn S Nelson, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 337 11th St Sw, Spencer, IA 51301 Phone: 712-580-4570 Fax: 712-580-4573 | |
Ms. Kimberly Whisenant, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 116 E 11th St Ste 101, Spencer, IA 51301 Phone: 712-264-3500 Fax: 712-264-3525 |